TheraRadar
Data updated: Mar 29, 2026

ELLIOTTS B SOLUTION

CALCIUM CHLORIDE
Approved 1996-09-27

Ringer’s Injection is indicated for use as a source of water and electrolytes in adults and pediatric patients. Ringer’s Injection is indicated for use as a source of water and electrolytes in adults and pediatric patients. ( 1 )...

Source: FDA Label • LUKARE MEDICAL LLC
1
Indication
--
Phase 3 Trials
1
Priority Reviews
29
Years on Market

Details

Status
Prescription
First Approved
1996-09-27
Routes
INTRATHECAL
Dosage Forms
INJECTABLE

ELLIOTTS B SOLUTION Approval History

Loading approval history...

What ELLIOTTS B SOLUTION Treats

1 FDA approvals

Originally approved for its first indication in 1996 .

  • Other (1)
🔬

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
📊

Trial Timeline

Full development history with FDA approval milestones

|
Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

ELLIOTTS B SOLUTION FDA Label Details

Pro

Indications & Usage

Ringer’s Injection is indicated for use as a source of water and electrolytes in adults and pediatric patients. Ringer’s Injection is indicated for use as a source of water and electrolytes in adults and pediatric patients.

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.